Appears On
Episode Appearances
The Ezra Klein Show · May 8, 2026
GLP-1s and the ‘Wild West’ of Wellness
“Helped discover GLP-1 drug class; described three-bucket mechanism (weight loss, inflammation, organ targeting)”
GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) mechanisms and efficacyWeight loss as appetite suppression vs. metabolism increaseCardiovascular and organ-protective benefits independent of weight loss
View Analysis